PRDX1 and chronic obstructive pulmonary disease: Therefore, the nomogram combined with the LRG signatures (CBR1 and PRDX1) effectively predicts the risk of COPD and exhibits significant advantages in terms of accuracy, stability, and clinical applicability, which holds considerable promise as a tool for early COPD diagnosis and personalized strategies.